Breaking Down CastleArk Alternatives Q2 2022 vs. Q3 2022 13F Holdings
Ava Hoppe | 2 May, 2023
Investing in the stock market is an excellent way to earn money, but it can be challenging to navigate without the right tools and strategies. Luckily, there are many investment firms that help investors navigate the often complicated world of stock market investments. One such firm is CastleArk Alternatives, which publishes their 13F holdings reports to help investors make informed decisions.
In this article, we'll be taking a look at the changes in holdings between Q2 2022 and Q3 2022 for CastleArk Alternatives, LLC. We'll be analyzing the data and breaking it down to see what changes were made and why.
Before we get started, it's important to note that these holdings are subject to change even after the Q3 2022 report, and that past performance is not indicative of future results. As with any investment, do your due diligence and consult with a financial advisor before making any decisions.
With that out of the way, let's take a closer look at the data.
Top Holdings by Shares
The Q2 2022 report showed that CastleArk Alternatives' top holdings by shares included Proshares TR (TQQQ), Southwestern Energy Co (SWN), EQT Corp (EQT), and Cheniere Energy Inc (LNG), with 90,000, 115,700, 16,090, and 3,420 shares, respectively.
In the Q3 2022 report, some changes were made to the top holdings. TQQQ remained at the top, but the number of shares increased to 95,000. SWN remained the same at 115,700 shares, but the value decreased by 2.1%. EQT Corp also remained the same with 16,090 shares, but the value increased by 18.6%. LNG remained the same at 3,420 shares, but the value increased by 24.6%.
Top Holdings by Value
The Q2 2022 report showed that CastleArk Alternatives' top holdings by value included TQQQ, Cheniere Energy Inc (LNG), Devan Energy Corp New (DVN), and Magnolia Oil & Gas Corp (MGY), with a value of $2,160,000, $455,000, $392,000, and $405,000, respectively.
In the Q3 2022 report, some changes were made to the top holdings by value. TQQQ remained at the top, but the value decreased by 15%. LNG remained the same at second place, but the value increased by 24.6%. DVN increased its value from $392,000 to $428,000, a change of 9.2%. MGY decreased in value from $405,000 to $382,000, a change of 5.7%.
New Purchases
CastleArk Alternatives, LLC made no new purchases in Q3 2022.
Sold Out
CastleArk Alternatives, LLC sold out of two holdings in Q3 2022. These holdings were Schlumberger Ltd (SLB) and Patterson-UTI Energy Inc (PTEN).
Biggest Changes
The biggest changes in holdings between Q2 2022 and Q3 2022 for CastleArk Alternatives, LLC were in the holdings of Marathon Oil Corp (MRO) and Delek US Hldgs Inc New (DK). MRO decreased in value from $404,000 to $203,000, a change of 49.8%. DK also decreased in value from $502,000 to $202,000, a change of 59.8%.
Conclusion
CastleArk Alternatives, LLC made some significant changes to their holdings between Q2 2022 and Q3 2022. While some holdings remained the same, others changed significantly in either shares or value. It's important to note that these holdings are subject to change even after the Q3 2022 report, and that past performance is not indicative of future results. As always, it's important to do your due diligence and consult with a financial advisor before making any investment decisions.
Other Posts
- The Profound Shifts in Pring Turner Capital Group's Portfolio: Q3 2022 vs. Q4 2022
- Navigating Growth: How PestCo Holdings' Latest Acquisition Reinforces Its Market Presence
- Changes in Holdings of Funds: Summitry LLC Q3 2022 vs. Q4 2022
- Electrifying the Future: How Criticore's Latest Move Sparks a Brighter Vision for Electrical Services
- Aegis Financial Corp Q2 2023 vs. Q3 2023 13F Holdings Comparison
- Changes in Holdings of Phoenix Investment Adviser LLC Q2 2019 vs. Q3 2019
- Sailing Beyond the Horizon: How Palm Beach Capital’s Latest Triumph Redefines Middle Market Mastery
- Unlocking Doors and Securing Futures: Cobalt's Strategic Acquisition Spree Lights the Way
- Investment Firm SCP's Q3 and Q4 2022 13F Holdings Comparison: Analysis and Insights
- Endeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. to Board of Directors